Mitsubishi UFJ Asset Management’s Caris Life Sciences CAI Stock Holding History

Mitsubishi UFJ Asset Management’s Portfolio CAI Stock Details CAI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.53M	Buy	+85,600	New	+$1.53M	﹤0.01%	807

Other funds holding CAI

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

ZCI

Zevenbergen Capital Investments Edmonds, Washington $4.38B AUM 56.68% 1-Year Est. Return

Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

SIC

Salem Investment Counselors Winston Salem, North Carolina $4.03B AUM 61.49% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Mitsubishi UFJ Asset Management's CAI Position: Q2 2026 in Review

Mitsubishi UFJ Asset Management opened a new position in Caris Life Sciences (CAI) in Q2 2026: 85,600 shares worth $1.53M. The stake represents ﹤0.01% of the portfolio and ranks #807 among its holdings.

86 funds tracked by Wall St. Rank hold CAI as of Q2 2026.

Mitsubishi UFJ Asset Management held 85,600 shares of Caris Life Sciences worth $1.53M as of Q2 2026.
Caris Life Sciences was a new Mitsubishi UFJ Asset Management position in Q2 2026.
Caris Life Sciences made up ﹤0.01% of Mitsubishi UFJ Asset Management's portfolio in Q2 2026, its #807 holding.
86 funds tracked by Wall St. Rank held Caris Life Sciences as of Q2 2026.

Based on Mitsubishi UFJ Asset Management's 13F filing for Q2 2026, filed 7 Aug 2026.